Variability in the presence of the metabolic syndrome in Type 2 diabetic patients attending a diabetes clinic. Influences of age and gender

Diabetes Research and Clinical Practice
F RelimpioR Astorga

Abstract

In this study, we have assessed age and gender-related influences on the presence of the metabolic syndrome (MS) and closely related variables in Type 2 diabetic patients attending a diabetes clinic. For this purpose, we have taken retrospective clinical and biochemical data from consecutive Type 2 diabetic patients (n = 291) and we have classified them by gender, age (with 55 and 70 years as cut-off levels) and having or not having the MS (using both the WHO and NCEP-ATP III MS definitions). A higher prevalence of adiposity and hypertension was present in the females. Males were characterized by higher uric acid and lower HDL-cholesterol and apoA(1) levels (two-way ANOVA considering jointly age and gender as main effects, P < 0.05 in every case). Overall the prevalence of NCEP-ATP III-defined MS was less frequent than WHO-defined MS (63.2% versus 81.1%, respectively). This difference was greater for males (42.1% versus 77.6%, respectively) than for females (75.5% versus 83.2% respectively). The kappa-coefficient for the concordance between both MS definitions was 0.46 for males and 0.72 for females in the first age band, 0.29 for males and 0.48 for females in the second age band and 0.24 for males and 0.51 for females in the t...Continue Reading

References

Apr 30, 1987·The New England Journal of Medicine·G A ColditzC H Hennekens
Oct 22, 1987·The New England Journal of Medicine·J Mohle-Boetani, A Whittemore
Mar 27, 1999·Lancet·G Ross, J Stier
Mar 27, 1999·Lancet·E Sanchez-Delgado, H Liechti
Jun 11, 1999·The New England Journal of Medicine·M E Mendelsohn, R H Karas
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Feb 28, 2002·Cardiovascular Research·Jacques E Rossouw
Mar 5, 2002·Diabetes Care·Allan D SnidermanJiri Frohlich
Dec 4, 2002·JAMA : the Journal of the American Medical Association·Hanna-Maaria LakkaJukka T Salonen

❮ Previous
Next ❯

Citations

Jan 4, 2008·Cardiovascular Diabetology·Nicholas TentolourisNicholas Katsilambros
Feb 23, 2013·International Journal of Endocrinology·Chung-Hua Hsu
Sep 24, 2013·Revista española de geriatría y gerontología·María Elena Castro VilelaFernando Calvo Gracia
Feb 16, 2010·Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición·Angel Rodríguez BernardinoManuel Serrano Ríos
Jul 28, 2007·Diabetes/metabolism Research and Reviews·Nasser M Al-DaghriReem Sallam
Apr 29, 2005·Diabetes/metabolism Research and Reviews
Nov 9, 2005·Journal of the American Geriatrics Society·Jeanette S Brown
May 10, 2016·Endocrine Reviews·Alexandra Kautzky-WillerGiovanni Pacini
Jul 30, 2005·Diabetes/metabolism Research and Reviews·Gian Piero Carnevale SchiancaEttore Bartoli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Risk Prediction

Cardiovascular risk prediction models based on classical risk factors identified in epidemiological studies are useful in primary prevention of cardiovascular disease in individuals. Here is the latest research.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.